Wellington Management Group
ICCC icon

Wellington Management Group’s ImmuCell ICCC Stock Holding History

Wellington Management Group’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-386,260
Closed -$1.46M – 1902
2020
Q1 		$1.46M Sell
386,260
-297,074
-43% -$1.46M ﹤0.01% 1429
2019
Q4 		$3.52M Hold
683,334
– – ﹤0.01% 1411
2019
Q3 		$3.79M Hold
683,334
– – ﹤0.01% 1417
2019
Q2 		$4.44M Hold
683,334
– – ﹤0.01% 1405
2019
Q1 		$4.34M Buy
+683,334
New +$4.88M ﹤0.01% 1410

Other funds holding ICCC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OMC
Overbrook Management Corp New York $529M AUM 31.5% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SRC
Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group's ICCC Position: Q2 2020 in Review

Wellington Management Group sold out of ImmuCell (ICCC) in Q2 2020, closing a stake of 386,260 shares — an estimated $1.46M sold.

Wellington Management Group first reported a position in ICCC in Q1 2019 and held it in 5 quarters. The position peaked at $4.44M in Q2 2019. 24 funds tracked by Wall St. Rank hold ICCC as of Q2 2020.

  • Wellington Management Group reported no remaining ImmuCell position as of Q2 2020 after selling out during the quarter.
  • Wellington Management Group sold 386,260 ImmuCell shares in Q2 2020, an estimated $1.46M.
  • Wellington Management Group first reported a position in ImmuCell in Q1 2019 and held it in 5 quarters.
  • Wellington Management Group's ImmuCell position peaked at $4.44M in Q2 2019.
  • 24 funds tracked by Wall St. Rank held ImmuCell as of Q2 2020.

Based on Wellington Management Group's 13F filing for Q2 2020, filed 14 Aug 2020.